• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CDY
Click for more information
1.43% 7.1¢

CELLMID LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CDY Cellmid Investor Newsletter26/03/19
CDY Minimum Holding Share Buy-BackPRICE SENSITIVE19/03/19
CDY Appendix 4D, Half Year Accounts and Strategy UpdatePRICE SENSITIVE21/02/19
CDY Significant New Findings Published on MidkinePRICE SENSITIVE07/02/19
CDY Appendix 4C and Notes to Appendix 4CPRICE SENSITIVE23/01/19
CDY Cellmid Expects Record Sales in Q2 FY2019PRICE SENSITIVE12/12/18
CDY Cellmid Appoints Exclusive New Zealand DistributorPRICE SENSITIVE19/11/18
CDY Change of Director's Interest Notice - Halasz13/11/18
CDY Change of Director's Interest Notice - Eck13/11/18
CDY Appendix 3B and Cleansing Notice12/11/18
CDY Results of Annual General Meeting08/11/18
CDY AGM Presentation to Shareholders08/11/18
CDY New Patents for Midkine Antibodies in USA and EuropePRICE SENSITIVE07/11/18
CDY Ikon Legal Action - DecisionPRICE SENSITIVE02/11/18
CDY Trading HaltPRICE SENSITIVE02/11/18
CDY Cellmid's Evolis Successfully Launched in USA storesPRICE SENSITIVE01/11/18
CDY Repayment of R&D LoanPRICE SENSITIVE01/11/18
CDY Investor PresentationPRICE SENSITIVE31/10/18
CDY Cellmid receives R&D tax credit30/10/18
CDY Appendix 4C and Notes to Appendix 4CPRICE SENSITIVE15/10/18
CDY Notice of Annual General Meeting/Proxy Form09/10/18
CDY Appendix 3B and Cleansing Notice08/10/18
CDY Cleansing Notice03/10/18
CDY Appendix 3B03/10/18
CDY Appendix 3B28/09/18
CDY Change of Registry Address: Automic P/L - Sydney Office28/09/18
CDY Appendix 4G and Corporate Governance Statement27/09/18
CDY Annual Report to shareholders27/09/18
CDY Change of Director's Interest Notice - Gordon25/09/18
CDY Clarification Announcement24/09/18
CDY CDY Investor Newsletter - 21 September 201821/09/18
CDY Date of Annual General Meeting19/09/18
CDY Full Year Statutory Accounts19/09/18
CDY Becoming a substantial holder14/09/18
CDY Change of Director's Interest Notice-Cross13/09/18
CDY Change of Director's Interest Notice-Eck13/09/18
CDY Change of Director's Interest Notice-Gordon13/09/18
CDY Change of Director's Interest Notice-Halasz13/09/18
CDY Cleansing Notice12/09/18
CDY Appendix 3B12/09/18
CDY Lead Antibody Effective in Rare Chronic Kidney DiseasePRICE SENSITIVE12/09/18
CDY Results of Meeting07/09/18
CDY EGM Presentation by CEO07/09/18
CDY Company Secretary Appointment/Resignation06/09/18
CDY Cellmid Share Purchase Plan CompletionPRICE SENSITIVE03/09/18
CDY Evolis USA Distribution UpdatePRICE SENSITIVE30/08/18
CDY Preliminary Final ReportPRICE SENSITIVE24/08/18
CDY Cellmid Notice of Meeting06/08/18
CDY Cleansing Notice and Appendix 3BPRICE SENSITIVE06/08/18
CDY Cellmid Share Purchase PlanPRICE SENSITIVE31/07/18
CDY Cellmid Share Placement Raises $9MPRICE SENSITIVE31/07/18
CDY Appendix 4C and Notes to Appendix 4CPRICE SENSITIVE31/07/18
CDY Trading HaltPRICE SENSITIVE27/07/18 download Created with Sketch. 141.88KB
CDY CELLMID UPDATES ON DISTRIBUTION OF EVOLISPRICE SENSITIVE11/07/18 download Created with Sketch. 178.82KB
CDY CELLMID INVESTOR PRESENTATION02/07/18 download Created with Sketch. 2.51MB
CDY MIDKINE SYMPOSIUM MUNICH30/05/18 download Created with Sketch. 289.39KB
CDY CHANGE OF ADDRESS29/05/18 download Created with Sketch. 147.97KB
CDY CELLMID TO COMMENCE SELLING OF EVOLIS INTO CHINESE MARKETPRICE SENSITIVE02/05/18
CDY CELLMID SECURES BLOOMINGDALES USA PARTNERSHIP FOR EVOLISPRICE SENSITIVE24/04/18
CDY Appendix 4C - quarterlyPRICE SENSITIVE23/04/18
CDY Cellmid Investor Presentation10/04/18
CDY CELLMID CONVENING 5TH MIDKINE SYMPOSIUM IN MUNICH09/04/18
CDY CELLMID SIGNS DISTRIBUTION AGREEMENT FOR FILLERINAPRICE SENSITIVE04/04/18
CDY Change of Director's Interest Notice-Halasz29/03/18
CDY Initial Director's Interest Notice26/03/18
CDY CELLMID APPOINTS DENNIS ECK NON-EXECUTIVE DIRECTOR26/03/18
CDY Change of Director's Interest Notice-Halasz14/03/18
CDY Appendix 4D and Half Year AccountsPRICE SENSITIVE22/02/18
CDY Change of Director's Interest Notice-Halasz31/01/18
CDY Appendix 4C - quarterlyPRICE SENSITIVE25/01/18
CDY RECORD 2M SALES FOR CELLMID FGF5 INHIBITORSPRICE SENSITIVE10/01/18
CDY CELLMID QUARTERLY OPERATIONAL UPDATEPRICE SENSITIVE09/01/18
CDY Change of Director's Interest Notice-Halasz22/12/17
CDY Cleansing Statement & Appendix 3B19/12/17
CDY CELLMID PLACEMENT TO STRATEGIC INVESTORPRICE SENSITIVE15/12/17
CDY CELLMID SECURES NEW US RETAIL PARTNER FOR EVOLISPRICE SENSITIVE07/12/17
CDY CELLMID CAPITAL STRUCTURE POST CONSOLIDATION05/12/17
CDY YPB: Agreement with Cellmid to access Chinese health marketPRICE SENSITIVE28/11/17
CDY CELLMID SIGNS AGREEMENT WITH YPB FOR CHINA MARKET28/11/17
CDY CHANGE OF AUDITOR24/11/17
CDY Update - Consolidation/Split - CDY23/11/17
CDY Results of Annual General Meeting23/11/17
CDY AGM Presentation to Shareholders23/11/17
CDY Appendix 3B-Unlisted options16/11/17
CDY ASIC Form 48415/11/17
CDY Change of Director's Interest Notice-Halasz15/11/17
CDY Appendix 3E and 3F15/11/17
CDY Change of Director's Interest Notice-Halasz07/11/17
CDY Change of Director's Interest Notice-Cross01/11/17
CDY Change of Director's Interest Notice-Walton01/11/17
CDY Initial Director's Interest Notice31/10/17
CDY Change of Director's Interest Notice-King31/10/17
CDY Change of Director's Interest Notice-Halasz31/10/17
CDY CELLMID PRESENTS AT WORLD CONGRESS FOR HAIR RESEARCH31/10/17
CDY CELLMID OPENS FIRST CONCEPT STORE IN TOKYOPRICE SENSITIVE26/10/17
CDY Announcement of buy-back - Appendix 3C25/10/17
CDY Appendix 4C - quarterlyPRICE SENSITIVE25/10/17
CDY PROPOSED CONSOLIDATION OF SECURITIESPRICE SENSITIVE24/10/17
CDY Consolidation/Split - CDYPRICE SENSITIVE23/10/17
CDY Cellmid Annual Report to Shareholders23/10/17
CDY Cellmid Investor Newsletter
26/03/19
CDY Minimum Holding Share Buy-Back
19/03/19PRICE SENSITIVE
CDY Appendix 4D, Half Year Accounts and Strategy Update
21/02/19PRICE SENSITIVE
CDY Significant New Findings Published on Midkine
07/02/19PRICE SENSITIVE
CDY Appendix 4C and Notes to Appendix 4C
23/01/19PRICE SENSITIVE
CDY Cellmid Expects Record Sales in Q2 FY2019
12/12/18PRICE SENSITIVE
CDY Cellmid Appoints Exclusive New Zealand Distributor
19/11/18PRICE SENSITIVE
CDY Change of Director's Interest Notice - Halasz
13/11/18
CDY Change of Director's Interest Notice - Eck
13/11/18
CDY Appendix 3B and Cleansing Notice
12/11/18
CDY Results of Annual General Meeting
08/11/18
CDY AGM Presentation to Shareholders
08/11/18
CDY New Patents for Midkine Antibodies in USA and Europe
07/11/18PRICE SENSITIVE
CDY Ikon Legal Action - Decision
02/11/18PRICE SENSITIVE
CDY Trading Halt
02/11/18PRICE SENSITIVE
CDY Cellmid's Evolis Successfully Launched in USA stores
01/11/18PRICE SENSITIVE
CDY Repayment of R&D Loan
01/11/18PRICE SENSITIVE
CDY Investor Presentation
31/10/18PRICE SENSITIVE
CDY Cellmid receives R&D tax credit
30/10/18
CDY Appendix 4C and Notes to Appendix 4C
15/10/18PRICE SENSITIVE
CDY Notice of Annual General Meeting/Proxy Form
09/10/18
CDY Appendix 3B and Cleansing Notice
08/10/18
CDY Cleansing Notice
03/10/18
CDY Appendix 3B
03/10/18
CDY Appendix 3B
28/09/18
CDY Change of Registry Address: Automic P/L - Sydney Office
28/09/18
CDY Appendix 4G and Corporate Governance Statement
27/09/18
CDY Annual Report to shareholders
27/09/18
CDY Change of Director's Interest Notice - Gordon
25/09/18
CDY Clarification Announcement
24/09/18
CDY CDY Investor Newsletter - 21 September 2018
21/09/18
CDY Date of Annual General Meeting
19/09/18
CDY Full Year Statutory Accounts
19/09/18
CDY Becoming a substantial holder
14/09/18
CDY Change of Director's Interest Notice-Cross
13/09/18
CDY Change of Director's Interest Notice-Eck
13/09/18
CDY Change of Director's Interest Notice-Gordon
13/09/18
CDY Change of Director's Interest Notice-Halasz
13/09/18
CDY Cleansing Notice
12/09/18
CDY Appendix 3B
12/09/18
CDY Lead Antibody Effective in Rare Chronic Kidney Disease
12/09/18PRICE SENSITIVE
CDY Results of Meeting
07/09/18
CDY EGM Presentation by CEO
07/09/18
CDY Company Secretary Appointment/Resignation
06/09/18
CDY Cellmid Share Purchase Plan Completion
03/09/18PRICE SENSITIVE
CDY Evolis USA Distribution Update
30/08/18PRICE SENSITIVE
CDY Preliminary Final Report
24/08/18PRICE SENSITIVE
CDY Cellmid Notice of Meeting
06/08/18
CDY Cleansing Notice and Appendix 3B
06/08/18PRICE SENSITIVE
CDY Cellmid Share Purchase Plan
31/07/18PRICE SENSITIVE
CDY Cellmid Share Placement Raises $9M
31/07/18PRICE SENSITIVE
CDY Appendix 4C and Notes to Appendix 4C
31/07/18PRICE SENSITIVE
CDY Trading Halt
27/07/18PRICE SENSITIVE download Created with Sketch. 141.88KB
CDY CELLMID UPDATES ON DISTRIBUTION OF EVOLIS
11/07/18PRICE SENSITIVE download Created with Sketch. 178.82KB
CDY CELLMID INVESTOR PRESENTATION
02/07/18 download Created with Sketch. 2.51MB
CDY MIDKINE SYMPOSIUM MUNICH
30/05/18 download Created with Sketch. 289.39KB
CDY CHANGE OF ADDRESS
29/05/18 download Created with Sketch. 147.97KB
CDY CELLMID TO COMMENCE SELLING OF EVOLIS INTO CHINESE MARKET
02/05/18PRICE SENSITIVE
CDY CELLMID SECURES BLOOMINGDALES USA PARTNERSHIP FOR EVOLIS
24/04/18PRICE SENSITIVE
CDY Appendix 4C - quarterly
23/04/18PRICE SENSITIVE
CDY Cellmid Investor Presentation
10/04/18
CDY CELLMID CONVENING 5TH MIDKINE SYMPOSIUM IN MUNICH
09/04/18
CDY CELLMID SIGNS DISTRIBUTION AGREEMENT FOR FILLERINA
04/04/18PRICE SENSITIVE
CDY Change of Director's Interest Notice-Halasz
29/03/18
CDY Initial Director's Interest Notice
26/03/18
CDY CELLMID APPOINTS DENNIS ECK NON-EXECUTIVE DIRECTOR
26/03/18
CDY Change of Director's Interest Notice-Halasz
14/03/18
CDY Appendix 4D and Half Year Accounts
22/02/18PRICE SENSITIVE
CDY Change of Director's Interest Notice-Halasz
31/01/18
CDY Appendix 4C - quarterly
25/01/18PRICE SENSITIVE
CDY RECORD 2M SALES FOR CELLMID FGF5 INHIBITORS
10/01/18PRICE SENSITIVE
CDY CELLMID QUARTERLY OPERATIONAL UPDATE
09/01/18PRICE SENSITIVE
CDY Change of Director's Interest Notice-Halasz
22/12/17
CDY Cleansing Statement & Appendix 3B
19/12/17
CDY CELLMID PLACEMENT TO STRATEGIC INVESTOR
15/12/17PRICE SENSITIVE
CDY CELLMID SECURES NEW US RETAIL PARTNER FOR EVOLIS
07/12/17PRICE SENSITIVE
CDY CELLMID CAPITAL STRUCTURE POST CONSOLIDATION
05/12/17
CDY YPB: Agreement with Cellmid to access Chinese health market
28/11/17PRICE SENSITIVE
CDY CELLMID SIGNS AGREEMENT WITH YPB FOR CHINA MARKET
28/11/17
CDY CHANGE OF AUDITOR
24/11/17
CDY Update - Consolidation/Split - CDY
23/11/17
CDY Results of Annual General Meeting
23/11/17
CDY AGM Presentation to Shareholders
23/11/17
CDY Appendix 3B-Unlisted options
16/11/17
CDY ASIC Form 484
15/11/17
CDY Change of Director's Interest Notice-Halasz
15/11/17
CDY Appendix 3E and 3F
15/11/17
CDY Change of Director's Interest Notice-Halasz
07/11/17
CDY Change of Director's Interest Notice-Cross
01/11/17
CDY Change of Director's Interest Notice-Walton
01/11/17
CDY Initial Director's Interest Notice
31/10/17
CDY Change of Director's Interest Notice-King
31/10/17
CDY Change of Director's Interest Notice-Halasz
31/10/17
CDY CELLMID PRESENTS AT WORLD CONGRESS FOR HAIR RESEARCH
31/10/17
CDY CELLMID OPENS FIRST CONCEPT STORE IN TOKYO
26/10/17PRICE SENSITIVE
CDY Announcement of buy-back - Appendix 3C
25/10/17
CDY Appendix 4C - quarterly
25/10/17PRICE SENSITIVE
CDY PROPOSED CONSOLIDATION OF SECURITIES
24/10/17PRICE SENSITIVE
CDY Consolidation/Split - CDY
23/10/17PRICE SENSITIVE
CDY Cellmid Annual Report to Shareholders
23/10/17
refresh Created with Sketch. REFRESH
 

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip Wealth Within chief analyst Dale Gillham and senior analyst Fil Tortevski have tipped $4.68 billion garbage giant Cleanaway Waste Management Limited (ASX:CWY) as their Hotcopper Hot Stock tip of the week @ especially because it seems to be slowly building towards a euphoric run akin to its mid 20...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.